Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kalka

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Vascular Medicine (London, England)|July 3, 2008
Gene and stem cell therapy in peripheral arterial occlusive diseaseC Kalka, Iris Baumgartner
Der Internist|May 8, 2002
[Cardiac and vascular gene therapy in cardiology. Current status and future prospects]C Kalka, J M Isner
Human Cell|May 2, 2001
Endothelial progenitor cells for regenerationH Masuda, C Kalka, T Asahara
Gene Therapy|April 11, 2000
Stem cell therapy and gene transfer for regenerationT Asahara, C Kalka, J M Isner
Herz|November 15, 2000
[Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization]C Kalka, T Asahara, W Krone, et al.
Annals of the New York Academy of Sciences|January 25, 2002
Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repairJ M Isner, C Kalka, A Kawamoto, et al.
Medizinische Klinik (Munich, Germany : 1983)|June 22, 1999
[Vascular endothelial factor (VEGF): therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease]C Kalka, T Takahashi, H Masuda, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|August 12, 2008
Distribution pattern of infrageniculate arterial obstructions in patients with diabetes mellitus and renal insufficiency - implications for revascularizationN Diehm, S Rohrer, I Baumgartner, et al.
Hamostaseologie|August 13, 2019
R Bauersachs, S Schellong, M Stücker, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER)N Kucher, D Spirk, C Kalka, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Vascular Medicine (London, England)|July 3, 2008
Gene and stem cell therapy in peripheral arterial occlusive diseaseC Kalka, Iris Baumgartner
Der Internist|May 8, 2002
[Cardiac and vascular gene therapy in cardiology. Current status and future prospects]C Kalka, J M Isner
Human Cell|May 2, 2001
Endothelial progenitor cells for regenerationH Masuda, C Kalka, T Asahara
Gene Therapy|April 11, 2000
Stem cell therapy and gene transfer for regenerationT Asahara, C Kalka, J M Isner
Herz|November 15, 2000
[Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization]C Kalka, T Asahara, W Krone, et al.
Annals of the New York Academy of Sciences|January 25, 2002
Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repairJ M Isner, C Kalka, A Kawamoto, et al.
Medizinische Klinik (Munich, Germany : 1983)|June 22, 1999
[Vascular endothelial factor (VEGF): therapeutic angiogenesis and vasculogenesis in the treatment of cardiovascular disease]C Kalka, T Takahashi, H Masuda, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|August 12, 2008
Distribution pattern of infrageniculate arterial obstructions in patients with diabetes mellitus and renal insufficiency - implications for revascularizationN Diehm, S Rohrer, I Baumgartner, et al.
Hamostaseologie|August 13, 2019
R Bauersachs, S Schellong, M Stücker, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER)N Kucher, D Spirk, C Kalka, et al.
Pageof 3